Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-19-047610)

Filing Details

Accession Number:: 0001209191-19-047610
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-08-28 16:30:16
Reporting Period:: 2019-08-26

Accepted Time:: 2019-08-28 16:30:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1347178	Vanda Pharmaceuticals Inc.	VNDA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1263499	W Richard Dugan	298 Beacon Circle Boalsburg PA 16827		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-08-26	15,000	$14.78	50,770	No	4	M	Direct
Common Stock	Disposition	2019-08-26	15,000	$14.85	35,770	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Nonstatutory Stock Option (Right to Buy)	Disposition	2019-08-26	15,000	$0.00	15,000	$14.78

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2019-08-26	No	4	M	Direct

Footnotes

Represents shares of common stock sold to cover the payment of the option exercise price (which represents 99.94% of the proceeds from the sales made by the Reporting Person) of the option, which was set to expire on August 26, 2019.
The option vested in 12 equal monthly installments beginning on September 27, 2009.